... outcome of less than 50% survival at one year after OLT is often regarded as prohibitive, given the scarce supply of donor organs. In our case, with acute hepatic failure pro- gressing despite treatment of the underlying ...
... Allogeneic stemcelltransplantation (allo-SCT) is nowadays the therapy of choice for several neoplastic and non-neoplastic diseases [1]. After allo-SCT, donor derived immunocompetent cells recognize ...
... neuron stemcell (NSC) transplantation therapy, have been studied for ...NSC transplantation effects, we were inspired to pretreat NSC using brain-derived neurotrophic factor (BDNF) before ...
... Wii games could be a useful tool to promote EP through play, providing the children with enjoyment and fun, key factors for obtaining high adherence in the pediatric popula- tion. Promising results discussed below show ...
... Background: Quality of life (QOL) is an important consideration in the counseling, implementation, and post-treatment management of arduous treatments for life-threatening conditions such as allogeneic hematopoietic ...
... (EBMT) (Ljungman et al., 2010) en la Unidad de TPH del Servicio de Hematología y Hemoterapia del “Hospital Universitario Virgen de las Nieves” de Gra- nada, que cumplían los siguie[r] ...
... dix, available with the full text of this article at NEJM.org.) All siblings were matched serologi- cally for HLA-A and HLA-B and by high-resolution DNA matching for HLA-DRB1 and HLA-DQB1 alleles. Patients were eligible ...
... In Colombia, a retrospective study of patients aged between 4 and 60 years with BMF, who received alloge- neic stemcelltransplantation from an identical relative between 1993 and 2011, found that ...
... 23. Ege H, Gertz MA, Markovic SN, Lacy MQ, Dispenzieri A, Hayman SR, et al. Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: a retrospective study. Haematol. Jun ...
... 91. Ruiz-Delgado GJ, Lutz-Presno JA, Alarcón-Urdaneta C, Calderón-García J, Ruiz-Argüelles GJ. Body mass index as an indicator of prognosis in patients undergoing allogeneic hematopoietic stemcell ...
... 3. Katzel J, Hari P, Vesole D. Multiple myeloma: charging toward a bright future. CA Cancer J Clin 2007;57:301-318. 4. Harousseau J, Moreau P. Autologous hematopoietic stem- celltransplantation for ...
... 1,000 stemcell transplants since their first transplant in May ...autologous stemcell transplant is a major therapeutic modality for patients with multiple ...for stemcell ...
... Material and method: An observational, longitudinal, retrospective, descriptive and comparative study was done with patients treated from 1990 to 2010, CML of novo, older than 15 years, both sexes. The clinical records ...
... Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation.. Use of micafungin ver[r] ...
... allogeneic stemcelltransplantation is attributed to tKe graft versus tumor effect produced by tKe infused donor immune effector cells to eradicate tumor ...the stemcell autograft ...
... 27. Jarisch A, Salzmann-Manrique E, Cario H, Grosse R, Soerensen J, Fischer R, et al. Serum ferritin is not a reliable predictor to determine iron overload in thalassemia major patients post-hematopoietic stem ...
... Donor cell leukemia after non- myeloablative allogeneic stemcelltransplantation: a single institution ...Hematopoietic CellTransplantation: How Will New and Established ...
... Single dose palonosetron 0.25 mg for the prevention of acute and delayed nausea and vomiting in patients undergoing HDCT and stem cell transplantation.. Paper presented at: 34th Annual M[r] ...
... beta cell-specific cfDNA (as determined from the frequency of molecules carrying a beta cell-specific methylation pattern) by the concentration of cfDNA measured in each particular ...